Shreyas Interm.

  • Market Cap: Micro Cap
  • Industry: Commodity Chemicals
  • ISIN: INE115F01017
  • NSEID:
  • BSEID: 526335
INR
7.81
-0.18 (-2.25%)
BSENSE

Jan 19

BSE+NSE Vol: 2.31 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

2.31 k (-50.85%) Volume

Shareholding (Sep 2025)

FII

8.42%

Held by 1 FIIs

DII

-0.00%

Held by 1 DIIs

Promoter

57.21%

Who are in the management team of Shreyas Interm.?

06-Jun-2025

As of March 2022, the management team of Shreyas Interm. includes Govind Krishna Sharma (Independent Director), Surya Prakash Pandey (Whole-time Director), Neelam Yashpal Arora (Independent Director), Bhavesh Vrujlal Gondaliya (Company Secretary & Compliance Officer), Dinesh Shankarlal Sharma (Non-Executive Director), and Nainesh Sumanti Rai Desai (Independent Director).

As of March 2022, the management team of Shreyas Interm. includes the following individuals:<BR><BR>1. Govind Krishna Sharma - Independent Director<BR>2. Surya Prakash Pandey - Whole-time Director<BR>3. Neelam Yashpal Arora - Independent Director<BR>4. Bhavesh Vrujlal Gondaliya - Company Secretary & Compliance Officer<BR>5. Dinesh Shankarlal Sharma - Non-Executive Director<BR>6. Nainesh Sumanti Rai Desai - Independent Director<BR><BR>These members play various roles within the company's governance and management structure.

View full answer

Has Shreyas Interm. declared dividend?

06-Jun-2025

No Dividend History Available

Who are the peers of the Shreyas Interm.?

03-Jun-2025

Shreyas Interm.'s peers include Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex. In terms of returns, India Glycols leads with 150.27% over one year, while Shreyas Interm. has a return of -9.56%.

Peers: The peers of Shreyas Interm. are Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, Fischer Medical, Sh. Hari Chem., Gayatri BioOrga., Genus Prime, and Camex.<BR><BR>Quality Snapshot: Excellent management risk is observed at GHCL, while Good management risk is found at Chemplast Sanmar and Sh. Hari Chem., and Average management risk is noted at Tata Chemicals and India Glycols. Below Average management risk is present at Fischer Medical and Camex, while Gayatri BioOrga., Genus Prime, and Shreyas Interm. do not qualify. Growth is Good at Sh. Hari Chem., while Below Average growth is seen at Tata Chemicals, Chemplast Sanmar, GHCL, India Glycols, and Camex. Average growth is noted at Fischer Medical, and the rest do not qualify. Capital Structure is Excellent at GHCL, Good at Fischer Medical, Average at Tata Chemicals, and Below Average at Chemplast Sanmar, India Glycols, Sh. Hari Chem., and Camex, while the rest do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is India Glycols at 150.27%, while the lowest is Tata Chemicals at -14.63%. Shreyas Interm.'s 1-year return is -9.56%, which is higher than Tata Chemicals but lower than the majority of its peers. Additionally, Camex and Tata Chemicals have negative six-month returns.

View full answer

Is Shreyas Interm. overvalued or undervalued?

09-Jun-2025

As of April 25, 2023, Shreyas Interm. is considered risky and overvalued due to negative earnings and unfavorable financial metrics, including a PE ratio of -42.92, while its year-to-date performance shows a decline of 23.72% compared to the Sensex's gain of 5.65%.

As of 25 April 2023, the valuation grade for Shreyas Interm. has moved from does not qualify to risky, indicating a significant change in its perceived financial health. The company appears to be overvalued based on its current metrics, with a PE ratio of -42.92, an EV to EBITDA of -75.07, and a Price to Book Value of 3.95. These ratios highlight the company's struggles, particularly with negative earnings and returns on capital employed and equity, which stand at -8.56% and -9.20%, respectively.<BR><BR>In comparison to its peers, Shreyas Interm. is positioned unfavorably against companies like Sudarshan Chemicals, which has a PE ratio of 71.32, and Kiri Industries, with a PE ratio of 13.72. This stark contrast further emphasizes the overvaluation of Shreyas Interm. Additionally, while the stock has shown a positive return of 3.85% over the past week compared to the Sensex's 1.45%, its year-to-date performance is concerning, with a decline of 23.72% against the Sensex's gain of 5.65%. Overall, the financial indicators suggest that Shreyas Interm. is overvalued in the current market environment.

View full answer

What is the technical trend for Shreyas Interm.?

09-Jun-2025

As of June 4, 2025, Shreyas Interm. shows a mildly bearish trend overall, with mixed signals from various indicators, including a mildly bullish weekly MACD and bearish monthly MACD.

As of 4 June 2025, the technical trend for Shreyas Interm. has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD remains bearish. The daily moving averages are mildly bearish, suggesting short-term weakness. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST indicates a mildly bullish trend weekly, but is mildly bearish monthly. Overall, the indicators present a mildly bearish stance with some mixed signals, particularly in the weekly timeframe.

View full answer

What does Shreyas Interm. do?

17-Jul-2025

Shreyas Intermediates Ltd manufactures dyes, pigments, and pigment intermediates in the Commodity Chemicals industry. As of March 2025, it reported a net profit of -3 Cr and has a market cap of INR 70 Cr.

Overview: <BR>Shreyas Intermediates Ltd is engaged in the manufacturing of Dyes, Pigments, and Pigment Intermediates within the Commodity Chemicals industry and operates as a Micro Cap company.<BR><BR>History: <BR>Shreyas Intermediates Ltd was incorporated as a Private Limited Company on November 6, 1989, and was converted into a Public Limited Company in April 1992. The latest quarterly results reported a net profit of -3 Cr for March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: -3 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 70 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 33 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.45 <BR>Return on Equity: -9.20% <BR>Price to Book: 4.04<BR><BR>Contact Details: <BR>Address: D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722 <BR>Tel: 91-2356-272471 <BR>Email: accounts@shreyasintermediates.com <BR>Website: http://www.shreyaintermediates.co.in

View full answer

Who are the top shareholders of the Shreyas Interm.?

17-Jul-2025

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited with 27.59%, Invent Assets Securitisation And Reconstruction Pvt Ltd at 24.7%, and foreign institutional investors holding 8.53%. Promoter holdings are partially pledged at 10.028%.

The top shareholders of Shreyas Interm. include Kesar Petroproducts Limited, which holds the highest promoter stake at 27.59%. Additionally, the highest public shareholder is Invent Assets Securitisation And Reconstruction Pvt Ltd, with a holding of 24.7%. The company also has foreign institutional investors (FIIs) holding 8.53%, while individual investors account for 7.67% of the shares. Promoter holdings are partially pledged at 10.028%.

View full answer

How big is Shreyas Interm.?

24-Jul-2025

As of 24th July, Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr and reported net sales of 0.00 Cr with a net loss of 1.57 Cr over the last four quarters. Shareholder's funds are valued at 17.98 Cr, and total assets amount to 25.76 Cr.

As of 24th July, <BR><BR>Market Cap: Shreyas Intermediates Ltd has a market capitalization of 63.00 Cr, classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 0.00 Cr, while the sum of Net Profit for the same period shows a loss of 1.57 Cr.<BR><BR>Balance Sheet Snapshot: The reporting period is the latest annual period ending March 2024. Shareholder's Funds are valued at 17.98 Cr, and Total Assets amount to 25.76 Cr.

View full answer

When is the next results date for Shreyas Interm.?

07-Nov-2025

Shreyas Interm. will declare its results on 14 November 2025.

Shreyas Interm. will declare its results on 14 November 2025.

View full answer

How has been the historical performance of Shreyas Interm.?

03-Dec-2025

Shreyas Interm. has consistently reported zero net sales and persistent losses from March 2019 to March 2025, with negative operating profits and declining book value per share, indicating ongoing financial struggles and lack of revenue generation. Total liabilities and assets have also decreased during this period.

Answer:<BR>The historical performance of Shreyas Interm. shows consistent figures across several key financial metrics, primarily indicating a lack of operational revenue and persistent losses over the years.<BR><BR>Breakdown:<BR>Shreyas Interm. has reported zero net sales and other operating income from March 2019 to March 2025, resulting in total operating income remaining at 0.00 throughout this period. The company has incurred minimal employee costs, which have slightly increased from 0.00 in March 2019 to 0.02 in March 2025, while other expenses have fluctuated, peaking at 0.54 in March 2020 before declining to 0.39 in March 2023 and 0.39 in March 2025. Operating profit (PBDIT) has been negative, with losses ranging from -0.17 in March 2019 to -0.41 in March 2025. Profit before tax and profit after tax have also shown consistent losses, with figures of -1.59 in March 2025, reflecting a trend of increasing losses over the years. The company's total liabilities decreased from 31.64 in March 2020 to 24.66 in March 2025, while total assets followed a similar downward trend, falling from 31.64 to 24.66 in the same period. The book value per share has also declined from 2.82 in March 2020 to 1.75 in March 2025, indicating a deterioration in shareholder value. Overall, Shreyas Interm. has struggled with profitability and asset management, maintaining a stagnant operational status with no revenue generation.

View full answer

Should I buy, sell or hold Shreyas Intermediates Ltd?

10-Jan-2026

Why is Shreyas Intermediates Ltd falling/rising?

18-Jan-2026

As of 18-Jan, Shreyas Intermediates Ltd is experiencing a short-term rise in stock price to 7.99, driven by increased investor interest and recent gains. However, its long-term performance is weak, with a -31.36% return over the past year and ongoing financial challenges, indicating potential risks for investors.

As of 18-Jan, Shreyas Intermediates Ltd is experiencing a rise in its stock price, currently at 7.99, reflecting an increase of 0.38 or 4.99%. This upward movement can be attributed to several factors. Notably, the stock has outperformed its sector by 6.49% today and has shown consecutive gains over the last two days, accumulating a total return of 6.25% during this period. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 144.37% compared to the 5-day average, indicating heightened interest in the stock.<BR><BR>Despite these positive short-term indicators, it is important to note that the stock has been underperforming in the long term. Over the past year, it has generated a return of -31.36%, and its performance has lagged behind the benchmark indices consistently for the last three years. The stock is also trading below its moving averages across various time frames, suggesting a weaker long-term trend. Furthermore, the company faces challenges such as a high Debt to EBITDA ratio and a negative EBITDA, which contribute to its classification as a risky investment.<BR><BR>In summary, while Shreyas Intermediates Ltd is currently rising due to short-term gains and increased trading activity, its long-term fundamentals remain weak, which could pose risks for investors.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

  • Poor long term growth as Operating profit has grown by an annual rate 2.37% of over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
2

Risky - Negative EBITDA

3

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Commodity Chemicals

stock-summary
Market cap

INR 55 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

32

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.49

stock-summary
Return on Equity

-7.84%

stock-summary
Price to Book

3.58

Revenue and Profits:
Net Sales:
10 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.69%
0%
9.69%
6 Months
-16.65%
0%
-16.65%
1 Year
-31.91%
0%
-31.91%
2 Years
-36.61%
0%
-36.61%
3 Years
-36.09%
0%
-36.09%
4 Years
-6.91%
0%
-6.91%
5 Years
-17.27%
0%
-17.27%

Shreyas Interm. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

14-Jan-2026 | Source : BSE

Submission of Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations 2018 for the quarter ended 31st December 2025.

Closure of Trading Window

30-Dec-2025 | Source : BSE

Pursuant to provisions SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time and Shreyas Intermediates Limiteds Code of Conduct for Insiders the Trading Window for dealing in securities of the Company shall remain closed for Designated Persons (as defined in the Code) from 1st January 2026 till 48 hours after the announcement of the UFR of the Companyfor the quarter ended 31.12.2025.

Announcement under Regulation 30 (LODR)-Newspaper Publication

17-Nov-2025 | Source : BSE

Newspaper Cuttings in connection with the Un-audited Financial Results for the quarter and half year ended 30.09.2025 in terms of Regulation 30 & 47 of SEBI (LODR) Regulatins 2015.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
77.64%
EBIT Growth (5y)
2.37%
EBIT to Interest (avg)
-2.05
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.71
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
10.03%
Institutional Holding
8.42%
ROCE (avg)
-8.32%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
3.58
EV to EBIT
-36.54
EV to EBITDA
-64.30
EV to Capital Employed
2.74
EV to Sales
3.85
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-7.49%
ROE (Latest)
-7.84%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

10.028

Mutual Funds

Held by 3 Schemes (0.0%)

FIIs

Held by 1 FIIs (8.42%)

Promoter with highest holding

Kesar Petroproducts Limited' (27.59%)

Highest Public shareholder

Krish Pharma Speciality Private Limited (24.7%)

Individual Investors Holdings

7.76%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 64.08% vs 0.00% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 29.41% vs -13.33% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10.37",
          "val2": "6.32",
          "chgp": "64.08%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.07",
          "val2": "-0.03",
          "chgp": "333.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.24",
          "val2": "-0.34",
          "chgp": "29.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.68%",
          "val2": "-0.47%",
          "chgp": "1.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "16.69",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.04",
          "val2": "-0.30",
          "chgp": "113.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.58",
          "val2": "-0.91",
          "chgp": "36.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.24%",
          "val2": "0.00%",
          "chgp": "0.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 11.81% vs -0.70% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.38",
          "val2": "-0.43",
          "chgp": "11.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.27",
          "val2": "-1.44",
          "chgp": "11.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.41",
          "val2": "-0.39",
          "chgp": "-5.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.59",
          "val2": "-1.58",
          "chgp": "-0.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
10.37
6.32
64.08%
Operating Profit (PBDIT) excl Other Income
0.07
-0.03
333.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.24
-0.34
29.41%
Operating Profit Margin (Excl OI)
0.68%
-0.47%
1.15%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 64.08% vs 0.00% in Jun 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 29.41% vs -13.33% in Jun 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
16.69
0.00
Operating Profit (PBDIT) excl Other Income
0.04
-0.30
113.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.58
-0.91
36.26%
Operating Profit Margin (Excl OI)
0.24%
0.00%
0.24%
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is 36.26% vs -8.33% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.38
-0.43
11.63%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.27
-1.44
11.81%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in nine months ended Dec 2024 is 0.00% vs 0.00% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 11.81% vs -0.70% in Dec 2023

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.41
-0.39
-5.13%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-1.59
-1.58
-0.63%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2025 is 0.00% vs 0.00% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is -0.63% vs -0.64% in Mar 2024

stock-summaryCompany CV
About Shreyas Intermediates Ltd stock-summary
stock-summary
Shreyas Intermediates Ltd
Micro Cap
Commodity Chemicals
Shreyas Intermediates Limited (SIL) was incorporated as a Private Limited Company on November 6, 1989 and subsequently converted into a Public Limited Company in April, 1992. The Company was promoted by Dinesh S Sharma. The Company is engaged in manufacturing of Dyes, Pigments and Pigment Intermediates.In Dec.'93, the company came out with its initial public offering, aggregating Rs 3.
Company Coordinates stock-summary
Company Details
D-21 D-22 D-23 MIDC Inds Area, Lote Parshuram Taluka Khed Ratnagiri Maharashtra : 415722
stock-summary
Tel: 91-2356-272471
stock-summary
accounts@shreyasintermediates.com
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai